Liabilities / Assets
91st percentile
Higher debt load relative to assets than 91% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
91st percentile
Higher debt load relative to assets than 91% of similar nonprofits.
Liabilities / Revenue
78th percentile
Higher debt load relative to revenue than 78% of similar nonprofits.
Net Margin
96th percentile
Higher net margin than 96% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
$12,752,705
No earlier filing loaded for comparison.
Net Assets
$749,486
No earlier filing loaded for comparison.
Liabilities
$12,003,219
No earlier filing loaded for comparison.
Revenue
$11,795,887
No earlier filing loaded for comparison.
Expenses
$3,748,507
No earlier filing loaded for comparison.
Net Income
$8,047,380
No earlier filing loaded for comparison.
This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Canary Foundation is a public charity exempt from U.S. federal income tax under Section 501(c)(3) of the Internal Revenue Code in the United States. Canary Foundation of Canada is a Public Foundation registered with the Canada Revenue Agency; Business Number 82906 8550 RROOO1.The Canary Foundation has assembled teams of cancer researchers recognized by their peers as leaders in their disciplines from across multiple institutions and disciplines to attack the problem of early detection in a new, collaborative, action-oriented manner with the foremost objective of translating research into clinical applications. Canary differentiators include: * Dedication to early detection * Leaders in collaborative science * Focused and managed research * Best-in-class talent * 100% of donations goes to researchOne of the first decisions the Science Team made was to choose ovarian cancer as a prototype for creating an early detection blood test to detect trace amounts of proteins called biomarkers pro
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2011 • Form 990Summary only. Only limited summary data is available for this year.